Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis
Mu Yang, … , Xiaoyan Ding, Zhenglin Yang
Mu Yang, … , Xiaoyan Ding, Zhenglin Yang
Published June 14, 2022
Citation Information: JCI Insight. 2022;7(14):e158428. https://doi.org/10.1172/jci.insight.158428.
View: Text | PDF
Research Article Genetics Ophthalmology

CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis

  • Text
  • PDF
Abstract

Familial exudative vitreoretinopathy (FEVR) is a hereditary disorder that can cause vision loss. CTNND1 encodes a cellular adhesion protein p120-catenin (p120), which is essential for vascularization with unclear function in postnatal physiological angiogenesis. Here, we applied whole-exome sequencing to 140 probands of FEVR families and identified 3 candidate variants in the human CTNND1 gene. We performed inducible deletion of Ctnnd1 in the postnatal mouse endothelial cells (ECs) and observed typical phenotypes of FEVR with reactive gliosis. Using unbiased proteomics analysis combined with experimental approaches, we conclude that p120 is critical for the integrity of adherens junctions (AJs) and that p120 activates Wnt signaling activity by protecting β-catenin from glycogen synthase kinase 3 beta–ubiqutin–guided (Gsk3β-ubiquitin–guided) degradation. Treatment of CTNND1-depleted human retinal microvascular ECs with Gsk3β inhibitors LiCl or CHIR-99021 enhanced cell proliferation. Moreover, LiCl treatment increased vessel density in Ctnnd1-deficient mouse retinas. Variants in CTNND1 caused FEVR by compromising the expression of AJs and Wnt signaling activity. Genetic interactions between p120 and β-catenin or α-catenin revealed by double-heterozygous deletion in mice showed that p120 regulates vascular development through the Wnt/cadherin axis. In conclusion, variants in CTNND1 can cause FEVR through the Wnt/cadherin axis.

Authors

Mu Yang, Shujin Li, Li Huang, Rulian Zhao, Erkuan Dai, Xiaoyan Jiang, Yunqi He, Jinglin Lu, Li Peng, Wenjing Liu, Zhaotian Zhang, Dan Jiang, Yi Zhang, Zhilin Jiang, Yeming Yang, Peiquan Zhao, Xianjun Zhu, Xiaoyan Ding, Zhenglin Yang

×

Figure 7

Depletion of CTNND1 in HRECs inhibits in vitro EC angiogenesis and cell proliferation partially through inactivation of Wnt signaling activity.

Options: View larger image (or click on image) Download as PowerPoint
Depletion of CTNND1 in HRECs inhibits in vitro EC angiogenesis and cell ...
(A) Quantification of relative CTNND1, CCND1, MYC, JUN, DKK1, CD44, and CLDN5 mRNA levels detected by RT-qPCR in Ctrl and CTNND1-KD HRECs. Error bars, SDs. Student’s t test (n = 3), ****P < 0.0001. (B) Western blot analysis of protein levels of Wnt signaling targets (p120, CyclinD1, c-Myc, and GLUT1) in Ctrl and CTNND1-KD HRECs. (C–E) Quantification of relative CyclinD1, c-Myc, and GLUT1 protein levels in Ctrl and CTNND1-KD HRECs. Error bars, SDs. Student’s t test (n = 3), *P < 0.05, ***P < 0.001, ****P < 0.0001. (F) Representative bright-field images of in vitro tube formation in Ctrl and CTNND1-KD HRECs. Scale bars, 25 μm. (G) Representative immunofluorescence images of Ctrl and CTNND1-KD HRECs labeled with EdU (red) and DAPI (blue). Scale bars, 50 μm. (H) Quantification of the percentage of EdU+ nuclei in Ctrl and CTNND1-KD HRECs. Error bars, SDs. Student’s t test (n = 5), ***P < 0.001. Experiments were performed at least 3 times independently.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts